|
 |
mecamylamine hydrochlorideThis page contains recent news articles, when available, and an overview of mecamylamine hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: mecamylamine hydrochloride (when available) Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small oral dosage often produces a smooth and predictable reduction of blood pressure. Although this antihypertensive effect is predominantly orthostatic, the supine blood pressure is also significantly reduced. Mecamylamine crosses the blood-brain and placental barriers. For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension Mechanism Of Action: Mecamylamine is a ganglionic blocker which prevents stimulation of postsynaptic receptors by acetylcholine released from presynaptic nerve endings. The hypotensive effect of Mecamylamine is attributed to reduction in sympathetic tone, vasodilation, and reduced cardiac output, and is primarily postural. News Articles on Mecamylamine Targacept Announces Plans To Develop Enantiomer Of Mecamylamine … - Oct 25, 2007 Mecamylamine hydrochloride is a racemic compound comprised of two mirror image halves known as the S+ and R- enantiomers. TC-5214 is the S+ enantiomer of ... Medical News Today - Medical News Today (press release) Targacept Scientists Make Multiple Presentations at Society for … - Nov 20, 2008 TC-5214 is the S(+) enantiomer of mecamylamine hydrochloride and has exhibited an overall therapeutic profile superior to racemic mecamylamine hydrochloride ... International Business Times Targacept Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation... - Jul 21, 2008 TC-5214 is the S(+) enantiomer of mecamylamine hydrochloride. TC-5214 has exhibited an overall therapeutic profile superior to mecamylamine in preclinical ... Lifescience-online Targacept Initiates Phase I Clinical Trial of TC-2216. - Jan 8, 2007 Mecamylamine hydrochloride binds non-selectively to various NNR subtypes, but there is a body of scientific evidence that suggests that its anti-depressant ... Free with registration - PR Newswire - AccessMyLibrary.com Stock Market Update, IPO profiles, Earnings Call Transcripts,... - Jan 17, 2006 TC-5231 is a low-dose reformulation of mecamylamine hydrochloride, ... The Company has reformulated mecamylamine hydrochloride as TC-5231 in a liquid gel ... 123Jump.com Targacept Presents Data from TRIDMAC(TM) Trial Showing Positive … - Jul 24, 2007 The data suggest that an add-on treatment of mecamylamine hydrochloride, a broad spectrum nicotinic antagonist, improved symptoms of depression in patients ... Genetic Engineering News - Genetic Engineering News (press release) Targacept Announces Plans to Develop Enantiomer of Mecamylamine as … - Oct 31, 2007 Mecamylamine hydrochloride is a racemic compound comprised of two mirror image halves known as the S+ and R- enantiomers. TC-5214 is the S+ enantiomer of ... carolinanewswire.com Targacept Reports Fourth Quarter and 2006 Financial Results. - Feb 22, 2007 Announced positive top line results of the Phase II clinical trial of mecamylamine hydrochloride as an augmentation therapy to citalopram hydrobromide, ... $4.95 - PR Newswire - ECNext Targacept reports progress in depression treatment The Business... - Nov 9, 2006 The trial is of mecamylamine hydrochloride, which the company believes may be able to enhance a commonly prescribed depression treatment that is sold under ... Bizjournals.com Targacept and AstraZeneca Announce Global License and Research … - Dec 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Free with registration - PR Newswire - AccessMyLibrary.com Competitors by Product Report - Sep 30, 2006 Targacept , Inc. (TRGT) Products:. Mecamylamine Hydrochloride; TC-1734 (Ispronicline). Taro Pharmaceutical Industries Ltd. (TARO) Products: ... $75.00 - Revere Reports - Revere Targacept compounds show long-lasting improvement in cognition - Jul 2, 2005 Targacept has a marketed product, InversineŠ¾ (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Medical News Today - Medical News Today (press release) Ispronicline Joins Effort to Find Alzheimer's Cure - Jul 6, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... SeniorJournal.com Targacept Initiates Clinical Development of TC-5214 as Augmentation … - Mar 17, 2008 TC-5214 is the S(+) enantiomer of the racemate mecamylamine hydrochloride, a broad spectrum NNR antagonist. In preclinical studies, TC-5214 has exhibited a ... Genetic Engineering News - Genetic Engineering News (press release) Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) … - May 17, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... Free with registration - PR Newswire - AccessMyLibrary.com Targacept compounds show long-lasting improvement in cognition - Jul 5, 2005 Targacept has a marketed product, InversineĀ® ( mecamylamine hydrochloride ), product candidates in clinical development for cognitive impairment, ... i-newswire.com Q2 2006 Targacept, Inc. Earnings Conference Call - Final. - Aug 9, 2006 And now, let's move onto mecamylamine hydrochloride. We anticipate that the date from our Phase II trial of mecamylamine as an add therapy for depression ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Targacept to Develop Enantiomer of Mecamylamine for Depression - Oct 24, 2007 Targacept plans to advance TC-5214, one of two enantiomers of mecamylamine hydrochloride, into clinical development as an augmentation therapy for patients ... FDA news - FDA news (subscription) CASM, GRRF, HIMX, TRGT, TZOO, WIT Have Been Removed From … - May 11, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Free with registration - M2 Presswire - AccessMyLibrary.com Acetylcholine release and choline uptake by cuttlefish (Sepia... - Feb 1, 2008 Furthermore, recent work on cuttlefish optic lobe slices (11) has shown that mecamylamine hydrochloride, a nicotinic receptor antagonist, blocks excitatory ... Pay-Per-View - Biological Bulletin - HighBeam Research Targacept to Present at Pacific Growth Equities 2005 Life Sciences … - Jun 2, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext Targacept to expand facilities at Piedmont Triad Research Park - Jan 31, 2007 In November 2006, Targacept reported positive top line results from a Phase II clinical trial of TRIDMAC(TM), which evaluated mecamylamine hydrochloride as ... carolinanewswire.com Link Between Smoking and Mental Illness May Lead to Treatments - Feb 1, 2006 ...but such improvements were lacking when these individuals were given mecamylamine hydrochloride, a drug that blocks nicotine's effects. ... Journal of American Medical Association - Journal of American Medical Association... Targacept Presents Promising Results at the 7th International... - Mar 29, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext Targacept to Report Second Quarter 2006 Financial Results on August... - Aug 9, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... prnewswire.com Targacept to Present at the Deutsche Bank 30th Annual Health Care … - Apr 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... $4.95 - PR Newswire - ECNext TARGACEPT REPORTS NET LOSS OF 5.5 MIL FOR FIRST QTR 2006. - Jul 1, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... Entrepreneur Targacept Reports First Quarter 2007 Financial Results. - May 9, 2007 Conducted additional preclinical testing and pharmaceutical development of TC-5214, an enantiomer of mecamylamine hydrochloride that the company expects ... $4.95 - PR Newswire - ECNext Press Release: Targacept to Present at the Deutsche Bank 30th Annual ... - Apr 28, 2005 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, ... Pay-Per-View - PR Newswire - HighBeam Research Targacept Reports Third Quarter 2007 Financial Results.(Financial... - Nov 8, 2007 In addition, we believe that the results of our Phase II clinical trial of mecamylamine hydrochloride as an augmentation therapy for major depression and ... $4.95 - Business Wire - ECNext Targacept Reports First Quarter 2006 Financial Results. - May 25, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... $4.95 - PR Newswire - ECNext Press Release: Targacept Reports First Quarter 2007 Financial... - May 9, 2007 Conducted additional preclinical testing and pharmaceutical development of TC-5214, an enantiomer of mecamylamine hydrochloride that the company expects ... Pay-Per-View - PR Newswire - HighBeam Research NFLX, TRGT, TWP, UTK, VNDA, AASP Have Also Been Added To Naked … - Apr 25, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... $4.95 - M2 Presswire - ECNext Press Release: Targacept to Expand Facilities at Piedmont Triad … - Jan 31, 2007 In November 2006, Targacept reported positive top line results from a Phase II clinical trial of TRIDMAC(TM), which evaluated mecamylamine hydrochloride as ... Pay-Per-View - PR Newswire - HighBeam Research Targacept to Report Second Quarter 2006 Financial Results on August... - Aug 2, 2006 Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive ... $4.95 - PR Newswire - ECNext Press Release: NFLX, TRGT, TWP, UTK, VNDA, AASP Have Also Been … - Apr 25, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Targacept Announces Positive Results of Phase II... - Nov 9, 2006 ...results from a double blind, placebo controlled Phase II clinical trial of mecamylamine hydrochloride as an augmentation treatment for major depression. ... Pay-Per-View - PR Newswire - HighBeam Research Targacept Reports Third Quarter 2006 Financial Results. - Nov 9, 2006 Internal Product Development Pipeline * Announced positive top line results of the Phase II clinical trial of mecamylamine hydrochloride as an augmentation ... $4.95 - PR Newswire - ECNext Press Release: CASM, GRRF, HIMX, TRGT, TZOO, WIT Have Been … - May 11, 2006 ...the treatment for acute post-operative pain; and TC-5214, a preclinical product candidate, which is a molecular component of mecamylamine hydrochloride. ... Pay-Per-View - M2 Presswire - HighBeam Research Brand Names/Synonyms: mecamylamine hydrochloride is also known by the following brand names and/or synonymsVersamine; Inversine; Revertina; Inversine hydrochloride; Mecamilamina; Mecamine; Mecamine hydrochloride; Mecamylamine Hydrochloride; Mekamin hydrochloride; Mekamine; Mevasin hydrochloride; Mevasine; 2-Methylamino-2,3,3-trimethylnorbornane; 2-Methylaminoisocamphane; 2-Norbornanamine, N,2,3,3-tetramethyl-; 2-Norbornanamine, N,2,3,3-tetramethyl-, hydrochloride; 3-Methylaminoisocamphane; 3-Methylaminoisocamphane hydrochloride Drug Category: mecamylamine hydrochloride is categorized under the following by the FDA: Antihypertensive Agents; Nicotinic Receptor Antagonist ATC:C02BB01 Dosage Forms: Tablets Absorption: Mecamylamine is almost completely absorbed from the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N,2,3,3-tetramethylnorbornan-2-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |